GRAVES-DISEASE - IMMUNOLOGICAL AND IMMUNOGENETIC INDICATORS OF RELAPSE

[21] THIONAMIDE THERAPY IN GRAVES-DISEASE - RELATION OF RELAPSE RATE TO DURATION OF THERAPY [J]. ANNALS OF INTERNAL MEDICINE, 1980, 92 (04) : 488 - 490

[22] CHANGES IN THYROID-STIMULATING ANTIBODY-ACTIVITY IN GRAVES-DISEASE TREATED WITH ANTI-THYROID DRUG AND ITS RELATIONSHIP TO RELAPSE - PROSPECTIVE-STUDY [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 50 (01) : 144 - 147

[23] INDUCTION OF CIRCULATING ACTIVATED SUPPRESSOR-LIKE T-CELLS BY METHIMAZOLE THERAPY FOR GRAVES-DISEASE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (01) : 15 - 22

[24] VANDERHEIDE D, 1980, LANCET, V1, P1376

[25] SIMULTANEOUS DETECTION OF 2 CELL-POPULATIONS BY 2-COLOR FLUORESCENCE AND APPLICATION TO RECOGNITION OF B-CELL DETERMINANTS [J]. NATURE, 1976, 262 (5571) : 795 - 797

[26] WEETMAN AP, 1986, Q J MED, V59, P409

[27] MODIFICATION OF CLASSIFICATION OF EYE CHANGES OF GRAVES-DISEASE - RECOMMENDATIONS OF AD-HOC COMMITTEE OF AMERICAN THYROID ASSOCIATION [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 44 (01) : 203 - 204

[28] THE ABILITY OF THE SERUM THYROTROPIN RECEPTOR ANTIBODY (TRAB) INDEX AND HLA STATUS TO PREDICT LONG-TERM REMISSION OF THYROTOXICOSIS FOLLOWING MEDICAL THERAPY FOR GRAVES-DISEASE [J]. CLINICAL ENDOCRINOLOGY, 1986, 25 (02) : 151 - 156

[29] WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x

[21] THIONAMIDE THERAPY IN GRAVES-DISEASE - RELATION OF RELAPSE RATE TO DURATION OF THERAPY [J]. ANNALS OF INTERNAL MEDICINE, 1980, 92 (04) : 488 - 490

[22] CHANGES IN THYROID-STIMULATING ANTIBODY-ACTIVITY IN GRAVES-DISEASE TREATED WITH ANTI-THYROID DRUG AND ITS RELATIONSHIP TO RELAPSE - PROSPECTIVE-STUDY [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 50 (01) : 144 - 147

[23] INDUCTION OF CIRCULATING ACTIVATED SUPPRESSOR-LIKE T-CELLS BY METHIMAZOLE THERAPY FOR GRAVES-DISEASE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (01) : 15 - 22

[24] VANDERHEIDE D, 1980, LANCET, V1, P1376

[25] SIMULTANEOUS DETECTION OF 2 CELL-POPULATIONS BY 2-COLOR FLUORESCENCE AND APPLICATION TO RECOGNITION OF B-CELL DETERMINANTS [J]. NATURE, 1976, 262 (5571) : 795 - 797

[26] WEETMAN AP, 1986, Q J MED, V59, P409

[27] MODIFICATION OF CLASSIFICATION OF EYE CHANGES OF GRAVES-DISEASE - RECOMMENDATIONS OF AD-HOC COMMITTEE OF AMERICAN THYROID ASSOCIATION [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 44 (01) : 203 - 204

[28] THE ABILITY OF THE SERUM THYROTROPIN RECEPTOR ANTIBODY (TRAB) INDEX AND HLA STATUS TO PREDICT LONG-TERM REMISSION OF THYROTOXICOSIS FOLLOWING MEDICAL THERAPY FOR GRAVES-DISEASE [J]. CLINICAL ENDOCRINOLOGY, 1986, 25 (02) : 151 - 156

[29] WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x